Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Heather A Leitch, MD, PhD, FRCPC, Christopher Chan, Chantal S Leger, MD, FRCP(C), Lynda M Foltz, MD, FRCP(C), Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Linda M Vickars, MD, FRCP(C)

Blood (2011) 118 (21): 1732.

https://doi.org/10.1182/blood.V118.21.1732.1732

Published: 2011

Journal Articles

Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease

Musa Alzahrani, MD, Mark C Hull, MD, Christopher Sherlock, MD, Deborah Griswold, MD, Chantal S Leger, MD, Shannon Jackson, MD, Christopher P Venner, BSc, MD, Tyler W Smith, MD, Heather A Leitch, MD, PhD

Blood (2010) 116 (21): 3897.

https://doi.org/10.1182/blood.V116.21.3897.3897

Published: 2010

Journal Articles

Clinical Features, Treatment, and Outcome of Severe HIV-Associated Immune Thrombocytopenic Purpura In the HAART Era

Kimberley LS Ambler, MD, FRCP(C), Linda M Vickars, MD, FRCP(C), Chantal S Leger, MD, FRCP(C), Lynda M Foltz, MD, FRCP(C), Julio SG Montaner, MD, FRCPC, FCCP, Marianne Harris, MD, FRCPC, Heather A Leitch, MD, PhD, FRCP(C)

Blood (2010) 116 (21): 2522.

https://doi.org/10.1182/blood.V116.21.2522.2522

Published: 2010

Journal Articles

A Scoring System Based on Clinical, Blood Count and Immunophenotypic Data Can Predict the Risk of Disease Progression in Patients with Chronic Lymphocytic Leukemia

Sina Alipour, BSc, Heather Leitch, MD, PhD, Linda M Vickars, MD, Lynda M Foltz, MD, Paul F Galbraith, MD, Chantal S Leger, MD, Khaled M Ramadan, MBBCh, FRCPI, FRCPath

Blood (2008) 112 (11): 4185.

https://doi.org/10.1182/blood.V112.11.4185.4185

Published: 2008

Journal Articles

CD38 Expression above 20% Predicts Disease Progression in Chronic Lymphocytic Leukemia and Is a Useful Prognostic Marker Where Cytogenetic and Molecular Markers Are Not Available

Sina Alipour, BSc, Heather Leitch, MD, PhD, Linda M Vickars, MD, Lynda M Foltz, MD, Paul F Galbraith, MD, Chantal S Leger, MD, Khaled M Ramadan, MBBCh, FRCPI, FRCPath

Blood (2008) 112 (11): 4190.

https://doi.org/10.1182/blood.V112.11.4190.4190

Published: 2008

Journal Articles

Richter Transformation of Chronic Lymphocytic Leukemia: Incidence, Risk Factors and Outcome

Sina Alipour, BSc, Heather Leitch, MD, PhD, Linda M Vickars, MD, Lynda M Foltz, MD, Paul F Galbraith, MD, Chantal S Leger, MD, Khaled M Ramadan, MBBCh, FRCPI, FRCPath

Blood (2008) 112 (11): 3179.

https://doi.org/10.1182/blood.V112.11.3179.3179

Published: 2008

Journal Articles

Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma

Hatoon Ezzat, MD, Matthew C Cheung, MD, SM, Lisa K Hicks, MD, MSc, Kevin C Murphy, MD, Chantal S Leger, MD, Linda R Taggart, MD, Jordana Boro, Julio SG Montaner, MD, Marianne Harris, MD, Linda M Vickars, MD, Heather A Leitch, MD, PhD

Blood (2008) 112 (11): 2587.

https://doi.org/10.1182/blood.V112.11.2587.2587

Published: 2008

Journal Articles

Improved Survival in Red Blood Cell Transfusion Dependent Patients with Primary Myelofibrosis (PMF) Receiving Iron Chelation Therapy.

Heather Leitch, MD, PhD, Hatoon Ezzat, MBBS, Meaghan D Rollins, BHK, Trisha A Goodman, BHK, Chantal S Leger, MD, Dominic HC Wong, BSc, Khaled M Ramadan, MB, Lynda M Foltz, MD, Linda M Vickars, MD

Blood (2008) 112 (11): 1748.

https://doi.org/10.1182/blood.V112.11.1748.1748

Published: 2008

Journal Articles

Improved Leukemia-Free and Overall Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy: A Subgroup Analysis.

Heather A. Leitch, MD, PhD, Dominic H.C. Wong, Chantal S. Leger, MD, Khaled M. Ramadan, MD, Meaghan D. Rollins, BHK, Michael J. Barnett, MB, Trisha A. Goodman, BHK, Karen K. Wong, Paul F. Galbraith, MD, Linda M. Vickars, MD

Blood (2007) 110 (11): 1469.

https://doi.org/10.1182/blood.V110.11.1469.1469

Published: 2007

Journal Articles

Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.

Heather A. Leitch, MD, PhD, Hatoon Ezzat, MD, Meaghan D. Rollins, BHK, Dominic H.C. Wong, Chantal S. Leger, MD, Khaled M. Ramadan, MD, Michael J. Barnett, MB, Linda M. Vickars, MD

Blood (2007) 110 (11): 4653.

https://doi.org/10.1182/blood.V110.11.4653.4653

Published: 2007

Journal Articles

Improved Survival in Patients with Myelodysplastic Syndrome (MDS) Receiving Iron Chelation Therapy.

Heather A. Leitch, MD, PhD, Trisha A. Goodman, BHK, Karen K. Wong, Linda M. Vickars, MD, Paul F. Galbraith, MD, Chantal S. Leger, MD

Blood (2006) 108 (11): 249.

https://doi.org/10.1182/blood.V108.11.249.249

Published: 2006

Journal Articles

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Hatoon Ezzat, MD, Douglas Filipinko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4666.

https://doi.org/10.1182/blood.V108.11.4666.4666

Published: 2006

Journal Articles

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

Hatoon Ezzat, MD, Jonathan C. Wong, BHSc, Douglas Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4667.

https://doi.org/10.1182/blood.V108.11.4667.4667

Published: 2006

Journal Articles

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Hatoon Ezzat, MD, J. Doug Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio Montaner, MD, Marianne Harris, MD, Robert Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4674.

https://doi.org/10.1182/blood.V106.11.4674.4674

Published: 2005

Journal Articles

Acute Leukemia in Patients Sixty Years of Age and Older: A Retrospective Review.

Chantal S. Leger, MD, Ann Lee, BSc, Heather A. Leitch, MD, PhD, Paul F. Galbraith, MD, Charles H. Li, MD, Linda M. Vickars, MD

Blood (2005) 106 (11): 4605.

https://doi.org/10.1182/blood.V106.11.4605.4605

Published: 2005

Journal Articles

Presenting Features Predictive of Long-Term Stability in Chronic Lymphocytic Leukemia.

Kortney L. Hillier, BSc, Sarah S. Fung, BA, Linda M. Vickars, MD, Chantal S. Leger, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4982.

https://doi.org/10.1182/blood.V106.11.4982.4982

Published: 2005

Journal Articles

Clinical Progression and Outcome of Patients with Monoclonal Lymphocytosis of Undetermined Significance.

Sarah S. Fung, BA, Kortney L. Hillier, BSc, Linda M. Vickars, MD, Chantal S. Leger, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4983.

https://doi.org/10.1182/blood.V106.11.4983.4983

Published: 2005

NARROW

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Clinical Presentation, Treatment and Outcome of HIV-Associated Multicentric Castleman Disease

Clinical Features, Treatment, and Outcome of Severe HIV-Associated Immune Thrombocytopenic Purpura In the HAART Era

A Scoring System Based on Clinical, Blood Count and Immunophenotypic Data Can Predict the Risk of Disease Progression in Patients with Chronic Lymphocytic Leukemia

CD38 Expression above 20% Predicts Disease Progression in Chronic Lymphocytic Leukemia and Is a Useful Prognostic Marker Where Cytogenetic and Molecular Markers Are Not Available

Richter Transformation of Chronic Lymphocytic Leukemia: Incidence, Risk Factors and Outcome

Incidence, Predictors, and Significance of Severe Toxicity in Patients with HIV-Associated Hodgkin Lymphoma

Improved Survival in Red Blood Cell Transfusion Dependent Patients with Primary Myelofibrosis (PMF) Receiving Iron Chelation Therapy.

Improved Leukemia-Free and Overall Survival in Patients with Myelodysplastic Syndrome Receiving Iron Chelation Therapy: A Subgroup Analysis.

Transfusion Dependence in Patients with Primary Myelofibrosis Has a Negative Impact on Survival Independent of Decreased Myelopoiesis.

Improved Survival in Patients with Myelodysplastic Syndrome (MDS) Receiving Iron Chelation Therapy.

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Acute Leukemia in Patients Sixty Years of Age and Older: A Retrospective Review.

Presenting Features Predictive of Long-Term Stability in Chronic Lymphocytic Leukemia.

Clinical Progression and Outcome of Patients with Monoclonal Lymphocytosis of Undetermined Significance.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only